FDA Inspection 906074 — Anika Therapeutics, Inc.

Anika Therapeutics, Inc. — FEI 3007093114

The FDA completed an inspection of Anika Therapeutics, Inc. on December 19, 2014 in Bedford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 19, 2014
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Bedford, MA (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
145121 CFR 211.113(b)Procedures for sterile drug products
192021 CFR 211.166(a)(3)Valid stability test methods
202721 CFR 211.192Investigations of discrepancies, failures
358321 CFR 211.110(a)Written in-process control procedures
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.